AbbVie : ABBV

All AbbVie Articles

565 Articles

Lee Jackson | Aug 30, 2022 at 7:22 AM EDT

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

The bear market rally that started in June is over and it is clearly a time to move to safer…

Chris Lange | Aug 1, 2022 at 11:55 AM EDT

July’s Recovery or Bear Market Rally: Analyst Upgrades or Downgrades include AbbVie, Bumble, Palo Alto Networks, Target and More

Monday's additional top analyst upgrades and downgrades included AbbVie, American Eagle, Bumble, Palo Alto Networks, SiriusXM, Stanley Black & Decker,…

Paul Ausick | Jul 27, 2022 at 12:24 PM EDT

Earnings Previews: AbbVie, Chevron, Exxon Mobil, Procter & Gamble

The two largest U.S. oil & gas companies report earnings before markets open Friday along with a pharmaceutical and a…

Lee Jackson | Jul 18, 2022 at 7:31 AM EDT

The 7 Highest-Yielding Dividend Aristocrats You Can Buy Now and Hold Forever

These seven top companies have some of the highest payouts in the Dividend Aristocrat universe. They supply products or services…

Lee Jackson | Jul 11, 2022 at 7:14 AM EDT

The 7 Highest-Yielding Dividend Kings to Buy Now and Hold Forever

Investors seeking dividend dependability may be drawn to the Dividend Kings, those companies that have raised their dividends for at…

Lee Jackson | Jul 5, 2022 at 9:23 AM EDT

We Are in a Recession: 7 Dividend Aristocrats Are the Best Second-Half Ideas

With the potential for massive downside still looming and interest rates definitely going higher, 24/7 Wall St. searched for Dividend…

Lee Jackson | Jun 13, 2022 at 7:31 AM EDT

7 ‘Strong Buy’ Dividend Kings to Own Now If the Fed Rate Increase This Week Is Huge

Investors worried about rising rates and stock volatility may want to consider these seven Dividend King stocks that should still…

Lee Jackson | Jun 6, 2022 at 9:37 AM EDT

9 ‘Strong Buy’ Dividend Aristocrats to Buy Now in Case Elon Musk Is Right

The founder of Tesla and SpaceX says he has a "super bad feeling" about the economy. These nine Dividend Aristocrats…

Lee Jackson | May 23, 2022 at 12:40 PM EDT

Another Dead Cat Bounce? Analysts Upgrade or Downgrade Dow, Gap, Pfizer and More

Monday's additional analyst calls were on AbbVie, Array Technologies, Dow, DTE Energy, Gap, Pfizer, Ralph Lauren, Trimble and more.

Lee Jackson | May 11, 2022 at 7:16 AM EDT

The 5 Highest-Yielding Dividend Kings May Be Among the Safest Stock Ideas Now

With the market seemingly poised to head much lower, it may be time for investors to move any capital invested…

Lee Jackson | May 6, 2022 at 9:01 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Amazon, APA, Costco, eBay, Etsy, Match, MetLife, Twilio, Uber, Virgin Galactic, Wayfair and More

Friday's top analyst upgrades and downgrades included AbbVie, Amazon.com, APA, CF Industries, Costco Wholesale, eBay, Etsy, GoDaddy, Intercontinental Exchange, Lululemon…

Lee Jackson | May 2, 2022 at 9:52 AM EDT

8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up

With the potential for a sizable correction looming, 24/7 Wall St. thought it would be a good idea to look…

Lee Jackson | Apr 28, 2022 at 7:15 AM EDT

7 ‘Strong Buy’ Dividend Kings to Move to Fast in Case of Total Market Meltdown

Any company that has paid rising dividends for 50 years or more is the epitome of safe and dependable. These…

Paul Ausick | Apr 27, 2022 at 12:03 PM EDT

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.

Lee Jackson | Apr 13, 2022 at 8:58 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, Shopify, Veru and More

Wednesday's top analyst upgrades and downgrades included AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, NetApp, Ping Identity, Shopify,…

1 … 7 8 9 10 11 … 38

AbbVie : ABBV

All AbbVie Articles

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

July’s Recovery or Bear Market Rally: Analyst Upgrades or Downgrades include AbbVie, Bumble, Palo Alto Networks, Target and More

Earnings Previews: AbbVie, Chevron, Exxon Mobil, Procter & Gamble

The 7 Highest-Yielding Dividend Aristocrats You Can Buy Now and Hold Forever

The 7 Highest-Yielding Dividend Kings to Buy Now and Hold Forever

We Are in a Recession: 7 Dividend Aristocrats Are the Best Second-Half Ideas

7 ‘Strong Buy’ Dividend Kings to Own Now If the Fed Rate Increase This Week Is Huge

9 ‘Strong Buy’ Dividend Aristocrats to Buy Now in Case Elon Musk Is Right

Another Dead Cat Bounce? Analysts Upgrade or Downgrade Dow, Gap, Pfizer and More

The 5 Highest-Yielding Dividend Kings May Be Among the Safest Stock Ideas Now

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Amazon, APA, Costco, eBay, Etsy, Match, MetLife, Twilio, Uber, Virgin Galactic, Wayfair and More

8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up

7 ‘Strong Buy’ Dividend Kings to Move to Fast in Case of Total Market Meltdown

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Wednesday’s Top Analyst Upgrades and Downgrades: AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, Shopify, Veru and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

AbbVie : ABBV

All AbbVie Articles

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

July’s Recovery or Bear Market Rally: Analyst Upgrades or Downgrades include AbbVie, Bumble, Palo Alto Networks, Target and More

Earnings Previews: AbbVie, Chevron, Exxon Mobil, Procter & Gamble

The 7 Highest-Yielding Dividend Aristocrats You Can Buy Now and Hold Forever

The 7 Highest-Yielding Dividend Kings to Buy Now and Hold Forever

We Are in a Recession: 7 Dividend Aristocrats Are the Best Second-Half Ideas

7 ‘Strong Buy’ Dividend Kings to Own Now If the Fed Rate Increase This Week Is Huge

9 ‘Strong Buy’ Dividend Aristocrats to Buy Now in Case Elon Musk Is Right

Another Dead Cat Bounce? Analysts Upgrade or Downgrade Dow, Gap, Pfizer and More

The 5 Highest-Yielding Dividend Kings May Be Among the Safest Stock Ideas Now

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Amazon, APA, Costco, eBay, Etsy, Match, MetLife, Twilio, Uber, Virgin Galactic, Wayfair and More

8 Dividend Aristocrat Leaders to Buy Now With the Stock Market Ready to Blow Up

7 ‘Strong Buy’ Dividend Kings to Move to Fast in Case of Total Market Meltdown

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Wednesday’s Top Analyst Upgrades and Downgrades: AbbVie, Blackstone, Boston Scientific, CarMax, Chewy, Eli Lilly, Medtronic, Shopify, Veru and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not